Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies

Leukemia. 2022 Mar;36(3):877-880. doi: 10.1038/s41375-021-01471-3. Epub 2021 Nov 20.

¹ Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. drsusanbal@gmail.com.
² University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
³ University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁴ Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
⁵ Washington University in St. Louis, St Louis, MO, USA.
⁶ Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
⁷ Vanderbilt University, Nashville, TN, USA.
⁸ Duke University, Durham, NC, USA.
⁹ University of Vermont, Burlington, VT, USA.
¹⁰ Medical College of Wisconsin, Milwaukee, WI, USA.
¹¹ Stanford University, Stanford, CA, USA.
¹² University of Wisconsin, Carbone Cancer Center, Madison, WI, USA.
¹³ Department of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

No abstract available

Publication types